What is the NOAEL for Balsams, peru?
Balsams, peru has 15 NOAEL studies in the database. The lowest reported value is 8.333 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Also known as: Balsam fir oil (Abies balsamea (L.) MilL.), Balsam fir oleoresin (Abies balsamea (L.) MilL.), Balsam oil, Peru, Balsam Peru, Balsam Peru oil (+9 more)
CAS 8007-00-9
Balsams, peru (CAS 8007-00-9) is a chemical substance. Key regulatory status: 18 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, SCCS.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| Canada; pharmaceutical | DrugBank | DrugBank |
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| active_ingredient; Australia | Australian Pesticides and Veterinary Medicines Authority | CPCat |
| active_ingredient; Pesticides | MN Department of Agriculture Pesticide Sales Database | CPCat |
| active_ingredient; Pesticides | MN Department of Agriculture Pesticide Sales Database | CPCat |
| active_ingredient; Pesticides | MN Department of Agriculture Pesticide Sales Database | CPCat |
| active_ingredient; Pesticides | MN Department of Agriculture Pesticide Sales Database | CPCat |
| IFRA Transparency | IFRA | IFRA |
| IFRA Transparency | IFRA | IFRA |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Europe; Personal care; restricted | European Commission | CosIng |
| Europe; Personal care - body oil | Danish Environmental Protection Agency | Danish EPA |
| banned; Europe; Personal care | European Commission | CosIng |
| IFRA Transparency | IFRA | IFRA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 40.42 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 8.333 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 8P5F881OCY | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8P5F881OCY | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8P5F881OCY | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8P5F881OCY | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| DIK0395679 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| DIK0395679 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| DIK0395679 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| DIK0395679 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3.093 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 17720 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 28640 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5906 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 2 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
Showing 15 of 15 studies
Australian industrial chemicals inventory status and applicable conditions.
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCP/0921/05 | 28 March 2006 | Crude Peru balsam exudate: banned (confirmed in SCCNFP/0771/03); Peru balsam extracts and distillates: conditionally safe at ≤0.4% | Crude exudate: banned (0%); Extracts and distillates: ≤0.4% in finished cosmetic product | Established sensitiser; cross-reactive with related resinous materials; wide variety of sensitisation test results; IFRA restriction predating this opinion |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
1 food-safety record found.
View full food safety profile →Balsams, peru has 15 NOAEL studies in the database. The lowest reported value is 8.333 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Balsams, peru appears on 8 regulatory/inventory lists including IFRA Transparency, Canada; pharmaceutical, active_ingredient; Australia, and 5 more. Source: EPA CPDat.
Yes, Balsams, peru is also indexed as a cosmetic ingredient under the name Peru Balsam. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS. All data traces to primary regulatory sources and is updated from official government databases.
Balsams, peru also appears in cosmetics, pharmaceutical, food safety databases.